Abstract

AbstractThe development of radiotracers for imaging solid tumors has recently focused on measuring a tumor's proliferative status. Two different strategies have emerged: (1) radiolabeled DNA precursors that measure DNA synthesis; and (2) radiotracers that label the sigma‐2 receptor, a putative biomarker of proliferation. This paper provides a brief description of these two different methods of imaging tumor proliferation that are currently being developed in the field of positron emission tomography (PET). Copyright © 2007 John Wiley & Sons, Ltd.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call